FOXP3 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "FOXP3" in Polish language version.

Last modified:

Ref.Un. Ref.Website
Global rank Polish rank
2nd place
5th place
5th place
7th place

doi.org (Global: 2nd place; Polish: 5th place)

  • L. Zhang, Y. Zhao. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.. „J Cell Physiol”. 211 (3), s. 590-7, Jun 2007. DOI: 10.1002/jcp.21001. PMID: 17311282.
  • A. Marson, K. Kretschmer, GM. Frampton, ES. Jacobsen i inni. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.. „Nature”. 445 (7130), s. 931-5, Feb 2007. DOI: 10.1038/nature05478. PMID: 17237765.
  • CL. Bennett, R. Yoshioka, H. Kiyosawa, DF. Barker i inni. X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3.. „Am J Hum Genet”. 66 (2), s. 461-8, Feb 2000. DOI: 10.1086/302761. PMID: 10677306.
  • M. Takenaka, N. Seki, U. Toh, S. Hattori i inni. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.. „Mol Clin Oncol”. 1 (4), s. 625-632, Jul 2013. DOI: 10.3892/mco.2013.107. PMID: 24649219.
  • KY. Won, HS. Kim, JY. Sung, GY. Kim i inni. Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas.. „Pathol Res Pract”. 209 (12), s. 767-73, Dec 2013. DOI: 10.1016/j.prp.2013.08.010. PMID: 24071443.
  • CL. Bennett, J. Christie, F. Ramsdell, ME. Brunkow i inni. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.. „Nat Genet”. 27 (1), s. 20-1, Jan 2001. DOI: 10.1038/83713. PMID: 11137993.

nih.gov (Global: 5th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • L. Zhang, Y. Zhao. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.. „J Cell Physiol”. 211 (3), s. 590-7, Jun 2007. DOI: 10.1002/jcp.21001. PMID: 17311282.
  • A. Marson, K. Kretschmer, GM. Frampton, ES. Jacobsen i inni. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.. „Nature”. 445 (7130), s. 931-5, Feb 2007. DOI: 10.1038/nature05478. PMID: 17237765.
  • CL. Bennett, R. Yoshioka, H. Kiyosawa, DF. Barker i inni. X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3.. „Am J Hum Genet”. 66 (2), s. 461-8, Feb 2000. DOI: 10.1086/302761. PMID: 10677306.
  • M. Takenaka, N. Seki, U. Toh, S. Hattori i inni. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.. „Mol Clin Oncol”. 1 (4), s. 625-632, Jul 2013. DOI: 10.3892/mco.2013.107. PMID: 24649219.
  • KY. Won, HS. Kim, JY. Sung, GY. Kim i inni. Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas.. „Pathol Res Pract”. 209 (12), s. 767-73, Dec 2013. DOI: 10.1016/j.prp.2013.08.010. PMID: 24071443.
  • CL. Bennett, J. Christie, F. Ramsdell, ME. Brunkow i inni. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.. „Nat Genet”. 27 (1), s. 20-1, Jan 2001. DOI: 10.1038/83713. PMID: 11137993.